Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial-Reference-Cited by-同舟云学术

Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial

Published:2020-10 Issue: Volume:228 Page:47-56
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Jensen Jesper,Omar Massar,Kistorp Caroline,Poulsen Mikael Kjær,Tuxen Christian,Gustafsson Ida,Køber Lars,Gustafsson Finn,Faber Jens,Fosbøl Emil L,Bruun Niels Eske,Brønd Jan Christian,Forman Julie Lyng,Videbæk Lars,Møller Jacob Eifer,Schou Morten

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials;Zelniker;Lancet,2019

2. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

4. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019

5. Dapagliflozin in patients with heart failure and reduced ejection fraction;JJV;N Engl J Med,2019

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: Determinants and relationship with patient-reported health status;American Heart Journal;2024-12

2. Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview of its Chemistry, Pharmacology, and Toxicology;Current Diabetes Reviews;2024-10

3. Sodium-dependent glucose transporter 2 inhibitors effects on myocardial function in patients with type 2 diabetes and asymptomatic heart failure;World Journal of Cardiology;2024-08-26

4. SGLT2i effect on atrial fibrillation: A network meta‐analysis of randomized controlled trials;Journal of Cardiovascular Electrophysiology;2024-06-28

5. The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis;Global Cardiology;2024-06-28